Complosome—the intracellular complement system
The complement system is a recognized pillar of host defence against infection and noxious
self-derived antigens. Complement is traditionally known as a serum-effective system …
self-derived antigens. Complement is traditionally known as a serum-effective system …
Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
Y Zhu, Y Chai, G **ao, Y Liu, X **e, W **ao… - Frontiers in …, 2022 - frontiersin.org
Fibrosis is the abnormal deposition of extracellular matrix, characterized by accumulation of
collagen and other extracellular matrix components, which causes organ dysfunction and …
collagen and other extracellular matrix components, which causes organ dysfunction and …
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure
Circulating proteomic signatures of age are closely associated with aging and age-related
diseases; however, the utility of changes in secreted proteins in identifying therapeutic …
diseases; however, the utility of changes in secreted proteins in identifying therapeutic …
The probiotic Lactobacillus casei Zhang-mediated correction of gut dysbiosis ameliorates peritoneal fibrosis by suppressing macrophage-related inflammation via the …
Z Wu, X Zuo, X Wang, M Shi, H Zhu, C Cao, X Liu… - Food & Function, 2023 - pubs.rsc.org
Peritoneal fibrosis is a complication of long-term peritoneal dialysis (PD) that restricts its
clinical application for the treatment of end-stage renal disease. Lactobacillus casei Zhang …
clinical application for the treatment of end-stage renal disease. Lactobacillus casei Zhang …
[HTML][HTML] Pathophysiological mechanisms of peritoneal fibrosis and peritoneal membrane dysfunction in peritoneal dialysis
Y Ito, T Sun, M Tawada, H Kinashi… - International Journal of …, 2024 - mdpi.com
The characteristic feature of chronic peritoneal damage in peritoneal dialysis (PD) is a
decline in ultrafiltration capacity associated with pathological fibrosis and angiogenesis. The …
decline in ultrafiltration capacity associated with pathological fibrosis and angiogenesis. The …
Novel aspects of the immune response involved in the peritoneal damage in chronic kidney disease patients under dialysis
F Trionfetti, V Marchant, GT González-Mateo… - International Journal of …, 2023 - mdpi.com
Chronic kidney disease (CKD) incidence is growing worldwide, with a significant percentage
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …
of CKD patients reaching end-stage renal disease (ESRD) and requiring kidney …
Selective activation of PPARα by pemafibrate mitigates peritoneal inflammation and fibrosis through suppression of NLRP3 inflammasome and modulation of …
Y Shinkai, K Sasaki, R Tamura, T Ike, A Takahashi… - Scientific Reports, 2024 - nature.com
Peritoneal inflammation and fibrosis remain major challenges to the long-term maintenance
of peritoneal dialysis. Pemafibrate, a selective peroxisome proliferator-activated receptor α …
of peritoneal dialysis. Pemafibrate, a selective peroxisome proliferator-activated receptor α …
Transglutaminases in fibrosis—overview and recent advances
F Soltani, MT Kaartinen - American Journal of Physiology …, 2023 - journals.physiology.org
Transglutaminases (TGs) are a family of protein cross-linking enzymes that are capable of
stiffening and insolubilizing proteins and creating protein networks, and thereby altering …
stiffening and insolubilizing proteins and creating protein networks, and thereby altering …
Current insights into cellular determinants of peritoneal fibrosis in peritoneal dialysis: A narrative review
Peritoneal fibrosis is the final process of progressive changes in the peritoneal membrane
due to chronic inflammation and infection. It is one of the main causes of discontinuation of …
due to chronic inflammation and infection. It is one of the main causes of discontinuation of …
HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells
Background Despite the significant progress achieved in understanding the pathology and
clinical management of SARS-CoV-2 infection, still pathogenic and clinical issues need to …
clinical management of SARS-CoV-2 infection, still pathogenic and clinical issues need to …